eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.sexual intimacy in old age not linked with memory loss
.
.
written reports, including local media accounts, professional medical papers and internal emails were also examined.
.
.